Relationship and Prognostic Significance of SPARC and VEGF Protein Expression in Colon Cancer

Overview

Journal J Exp Clin Cancer Res

Publisher Biomed Central

Specialty Oncology

Date 2010 Jun 23

PMID 20565704

Citations 39

Authors

Jian-Fang Liang

Hong-Kun Wang

Hong Xiao

Ning Li

Cai-Xia Cheng

Yu-Ze Zhao

Yan-b Ma

Jian-Zhong Gao

Rui-Bing Bai

Hui-Xia Zheng

Affiliations

Soon will be listed here.

Abstract

Background: SPARC (secreted protein, acidic and rich in cysteine) is closely related with the progress, invasion and metastasis of malignant tumor and angiogenesis.

Methods: Using human colon adenocarcinoma tissues (hereinafter referred to as colon cancer) and their corresponding non-diseased colon from 114 patients' biopsies, the expression of SPARC and vascular endothelial growth factor (VEGF) were investigated by immunohistochemistry staining to assessment the relationship between SPARC and VEGF, as well as their prognostic significance in patients. Evaluation of VEGF expression level with the same tissues was used to establish the antigenic profiles, and the marker of CD34 staining was used as an indicator of microvessel density (MVD).

Results: SPARC expression was mainly in the stromal cells surrounding the colon cancer, and was significant difference in those tissues with the lymph node metastasis and differentiation degree of tumor. Expression of SPARC was significantly correlated with the expression of VEGF and MVD in colon cancer tissues. Patients with low or absence expressing SPARC had significantly worse overall survival and disease-free survival in a Single Factor Analysis; Cox Regression Analysis, SPARC emerged as an overall survival and disease-free survival independent prognostic factor for colon cancer.

Conclusion: The low expression or absence of stromal SPARC was an independent prognostic factor for poor prognosis of colon cancer. SPARC maybe involved in the regulation of anti-angiogenesis by which it may serve as a novel target for colon cancer treatment as well as a novel distinctive marker.

Citing Articles

Effects of Exercise-Induced Changes in Myokine Expression on the Tumor Microenvironment.

Gunasekara N, Clauss D, Bloch W Sports Med Int Open. 2024; 8:a22831663.

PMID: 38933599 PMC: 11204211. DOI: 10.1055/a-2283-1663.

Nuclear localization of TET2 requires β-catenin activation and correlates with favourable prognosis in colorectal cancer.

Li C, He J, Meng F, Wang F, Sun H, Zhang H Cell Death Dis. 2023; 14(8):552.

PMID: 37620362 PMC: 10449923. DOI: 10.1038/s41419-023-06038-x.

Angiogenesis regulators S100A4, SPARC and SPP1 correlate with macrophage infiltration and are prognostic biomarkers in colon and rectal cancers.

Kazakova E, Rakina M, Sudarskikh T, Iamshchikov P, Tarasova A, Tashireva L Front Oncol. 2023; 13:1058337.

PMID: 36895491 PMC: 9989292. DOI: 10.3389/fonc.2023.1058337.

Modeling extracellular matrix through histo-molecular gradient in NSCLC for clinical decisions.

Baldavira C, Prieto T, Machado-Rugolo J, de Miranda J, de Oliveira L, Velosa A Front Oncol. 2022; 12:1042766.

PMID: 36452484 PMC: 9703002. DOI: 10.3389/fonc.2022.1042766.

Secreted Protein Acidic and Rich in Cysteine Mediates the Development and Progression of Diabetic Retinopathy.

Luo L, Sun X, Tang M, Wu J, Qian T, Chen S Front Endocrinol (Lausanne). 2022; 13:869519.

PMID: 35721704 PMC: 9205223. DOI: 10.3389/fendo.2022.869519.

References

Haber C, Gottifredi V, Llera A, Salvatierra E, Prada F, Alonso L . SPARC modulates the proliferation of stromal but not melanoma cells unless endogenous SPARC expression is downregulated. Int J Cancer. 2007; 122(7):1465-75. DOI: 10.1002/ijc.23216. View

Hasselaar P, Sage E . SPARC antagonizes the effect of basic fibroblast growth factor on the migration of bovine aortic endothelial cells. J Cell Biochem. 1992; 49(3):272-83. DOI: 10.1002/jcb.240490310. View

Koukourakis M, Giatromanolaki A, Brekken R, Sivridis E, Gatter K, Harris A . Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients. Cancer Res. 2003; 63(17):5376-80. View

Des Guetz G, Uzzan B, Nicolas P, Cucherat M, Morere J, Benamouzig R . Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature. Br J Cancer. 2006; 94(12):1823-32. PMC: 2361355. DOI: 10.1038/sj.bjc.6603176. View

Suzuki M, Hao C, Takahashi T, Shigematsu H, Shivapurkar N, Sathyanarayana U . Aberrant methylation of SPARC in human lung cancers. Br J Cancer. 2005; 92(5):942-8. PMC: 2361924. DOI: 10.1038/sj.bjc.6602376. View

Yunker C, Golembieski W, Lemke N, Schultz C, Cazacu S, Brodie C . SPARC-induced increase in glioma matrix and decrease in vascularity are associated with reduced VEGF expression and secretion. Int J Cancer. 2008; 122(12):2735-43. PMC: 3644882. DOI: 10.1002/ijc.23450. View

Yan Q, Sage E . SPARC, a matricellular glycoprotein with important biological functions. J Histochem Cytochem. 1999; 47(12):1495-506. DOI: 10.1177/002215549904701201. View

Chlenski A, Liu S, Crawford S, Volpert O, DeVries G, Evangelista A . SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis. Cancer Res. 2002; 62(24):7357-63. View

Teschendorff A, Miremadi A, Pinder S, Ellis I, Caldas C . An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer. Genome Biol. 2007; 8(8):R157. PMC: 2374988. DOI: 10.1186/gb-2007-8-8-r157. View

10.

Barth P, Moll R, Ramaswamy A . Stromal remodeling and SPARC (secreted protein acid rich in cysteine) expression in invasive ductal carcinomas of the breast. Virchows Arch. 2005; 446(5):532-6. DOI: 10.1007/s00428-005-1256-9. View

11.

Jendraschak E, Sage E . Regulation of angiogenesis by SPARC and angiostatin: implications for tumor cell biology. Semin Cancer Biol. 1996; 7(3):139-46. DOI: 10.1006/scbi.1996.0019. View

12.

Bradshaw A, Sage E . SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J Clin Invest. 2001; 107(9):1049-54. PMC: 209289. DOI: 10.1172/JCI12939. View

13.

Raines E, Lane T, Iruela-Arispe M, Ross R, Sage E . The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. Proc Natl Acad Sci U S A. 1992; 89(4):1281-5. PMC: 48433. DOI: 10.1073/pnas.89.4.1281. View

14.

Said N, Motamed K . Absence of host-secreted protein acidic and rich in cysteine (SPARC) augments peritoneal ovarian carcinomatosis. Am J Pathol. 2005; 167(6):1739-52. PMC: 1613196. DOI: 10.1016/S0002-9440(10)61255-2. View

15.

Koo C, Kok L, Lee M, Wu T, Cheng Y, Hsu J . Scoring mechanisms of p16INK4a immunohistochemistry based on either independent nucleic stain or mixed cytoplasmic with nucleic expression can significantly signal to distinguish between endocervical and endometrial adenocarcinomas in a tissue.... J Transl Med. 2009; 7:25. PMC: 2672079. DOI: 10.1186/1479-5876-7-25. View

16.

Ledda F, Bravo A, Adris S, Bover L, Mordoh J, Podhajcer O . The expression of the secreted protein acidic and rich in cysteine (SPARC) is associated with the neoplastic progression of human melanoma. J Invest Dermatol. 1997; 108(2):210-4. DOI: 10.1111/1523-1747.ep12334263. View

17.

Norose K, Clark J, Syed N, Basu A, Heber-Katz E, Sage E . SPARC deficiency leads to early-onset cataractogenesis. Invest Ophthalmol Vis Sci. 1998; 39(13):2674-80. View

18.

Kupprion C, Motamed K, Sage E . SPARC (BM-40, osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells. J Biol Chem. 1998; 273(45):29635-40. DOI: 10.1074/jbc.273.45.29635. View

19.

Gao J, Knutsen A, Arbman G, Carstensen J, Franlund B, Sun X . Clinical and biological significance of angiogenesis and lymphangiogenesis in colorectal cancer. Dig Liver Dis. 2008; 41(2):116-22. DOI: 10.1016/j.dld.2008.07.315. View

20.

Watkins G, Douglas-Jones A, Bryce R, Mansel R, Jiang W . Increased levels of SPARC (osteonectin) in human breast cancer tissues and its association with clinical outcomes. Prostaglandins Leukot Essent Fatty Acids. 2005; 72(4):267-72. DOI: 10.1016/j.plefa.2004.12.003. View